SWOG clinical trial number
SWOG-7812
Evaluation of Anguidine (NSC-141537) in the Treatment of Central Nervous System Tumors
Closed
Abbreviated Title
Evaluation of Anguidine (NSC-141537) in the Treatment of Central Nervous System Tumors
Activated
06/21/1978
Closed
02/12/1980
Publication Information Expand/Collapse
1983
Phase II evaluation of Anguidine in central nervous system tumors. A Southwest Oncology Group study.
Anguidine (Diacetoxyscerpenol) in central nervous system tumors. A Southwest Oncology Group study.